PLANTS

Language selector

Accessibility tools

Navigation path

Status under Reg. (EC) No 1107/2009 (repealing Directive 91/414/EEC )
Legislation Reg. (EU) No 1177/2013 Old Legislation Dossier complete 07/560/EC
Date of approval 01/05/2014 Expiration of approval 30/04/2024
RMS AT

Risk Assessment EFSA
Category IN Review Report
Remarks The Co-RMS is Norway
Authorisation at national level
Authorised in In progress for
AT, BE, CY, CZ, DE, DK, EL, ES, FI, FR, HR, HU, IE, IT, LU, MT, NL, PL, PT, RO, SE, UK BG, SI, SK
EU - Maximum Residue Levels (Reg. (EC) No 396/2005) (MRLs)
Legislation Annexes
  • Spirotetramat and its 4 metabolites BYI08330-enol, BYI08330-ketohydroxy, BYI08330-monohydroxy, and BYI08330 enol-glucoside, expressed as spirotetramat (R)
    MRLs Annex IIIA
Classification Reg. 1272/2008
Skin Sens. 1A - H317 Eye Irrit. 2 - H319
STOT SE 3 - H335 Repr. 2 - H361fd
Aquatic Acute 1 - H400 Aquatic Chronic 1 - H410
Toxicological information
Reference values Source Remark
ADI 0.05 EFSA 2013  
ARfD 1 EFSA 2013  
AOEL 0.05 EFSA 2013  
Other
 
Legend
  • RMS:Rapporteur Member State
  • Co-RMS:Co-Rapporteur Member State
  • ADI:Acceptable daily intake
  • ARfD:Acute reference dose
  • AOEL:Acceptable operator exposure level